AUTHOR SUMMARY
Synapses are cell adhesions between neurons, which constitute the fundamental functional units of the CNS. Formation of the correct type and number of synaptic connections is crucial for the proper development and function of our brains. In the past decade, researchers have recognized astrocytes, the major nonneuronal cell type of the brain, as important regulators of synapse formation. Here we identified two astrocyte-secreted proteins, hevin and SPARC, as regulators of excitatory synaptogenesis in vitro and in vivo. Hevin induces the formation of synapses between cultured rat retinal ganglion cells (RGCs). SPARC does not induce synapse formation, but specifically inhibits the synapse-promoting function of hevin. Concurrent with synaptogenesis, hevin and SPARC are expressed by astrocytes in the superior colliculus (SC), a brain region within the midbrain that serves as the synaptic target of RGCs. The mice that lacked hevin had fewer excitatory synapses; conversely, the mice that lacked SPARC had increased retinocollicular synaptic connections in the SC. Furthermore, we found that hevin is required for the structural maturation of these synapses, as the mice that lacked hevin had defects in the morphology of the pre-and postsynaptic specializations. These results identify hevin and SPARC as astrocyte-secreted factors that stimulate or inhibit synapse formation and signify that, through regulation of relative levels of hevin and SPARC, astrocytes control the formation, maturation, and plasticity of synapses in vivo.
Previous research has shown that astrocyte-secreted factors, including a family of ECM proteins, thrombospondins (TSPs), significantly increase the number of synapses formed between RGCs (1-3). These in vitro findings shed light on the importance of TSPs as regulators of synapse formation and injury-mediated synaptic remodeling in vivo (1) (2) (3) .
TSPs belong to a subclass of secreted proteins called matricellular proteins. Matricellular proteins function by modulation of cell-cell and cell-matrix interactions, and thereby regulate the adhesion of cells to each other or to the matrix. In this study, we investigated whether other astrocyte-secreted matricellular proteins also modulate synapse formation. Gene expression profiling of astrocytes suggested the matricellular proteins hevin [also known as synaptic cleft 1 (SC1) and SPARC-like 1] and SPARC as possible candidates. Hevin and SPARC are members of the secreted protein acidic and rich in cysteine (SPARC) family. Hevin was first identified as a synaptic cleft glycoprotein and was initially termed synaptic cleft-1, or SC1 (4).
Here we investigated whether hevin and SPARC contribute to synapse formation. We first tested the proteins' ability to stimulate synapse formation between purified rat RGCs in culture. In this culture system, RGCs survive and form dendritic and axonal processes, but do not form many synapses in the absence of any other cell type in a serum-free media of known composition. Addition of astrocyte feeder layers, astrocyteconditioned media, or purified TSPs robustly increases the number synapses (by three to seven fold) (1, 3). We found that, similarly to TSP, but unlike previously tested matrix and matrixassociated proteins, hevin is sufficient to induce the formation of synapses between cultured RGCs. SPARC does not induce synapse formation, but strongly inhibits hevin-induced synapse formation in vitro. Although both proteins promoted RGC neurite outgrowth in culture, we found that the synaptogenic function was exclusive to hevin. Previous studies suggested that hevin and SPARC had overlapping and redundant functions in vivo. These findings show that, contrary to what was previously thought, hevin and SPARC have independent and opposing roles in CNS synapse formation.
Exactly how does SPARC antagonize hevin? One possibility is that hevin and SPARC interact, and thus SPARC sequesters away hevin's synaptogenic activity. However, we did not find evidence of a direct interaction between these two molecules. Next we tested whether SPARC would inhibit hevin-induced . Astrocyte-secreted proteins hevin and SPARC control excitatory synaptogenesis in vitro and in vivo. Hevin induces the formation of synapses. SPARC is not synaptogenic, but specifically inhibits the synaptogenic function of hevin. Furthermore, we found that lack of hevin leads to defects in the recruitment of pre-and postsynaptic specializations at the RGC synapses in vitro and in vivo. These results identify hevin as a positive and SPARC as a negative regulator of synaptic development, and signify that, through regulation of relative levels of hevin and SPARC, astrocytes control the formation, maturation, and plasticity of synapses in the CNS.
synapse formation in a dominant-negative fashion. We engineered a truncated version of hevin that included the SPARC homology region. This hevin fragment (named SPARC-like fragment, or SLF) did not induce synapse formation like hevin, but instead blocked hevin-induced synapse formation, similar to SPARC. These results strongly suggest that SPARC most likely antagonizes hevin by competing with hevin's SPARC-like homology region during binding interactions with other proteins.
How do hevin and SPARC control synapse formation? The function of hevin in synapse formation might depend on its regulation of axon-dendrite adhesion. For example, hevin might act by clustering transsynaptic adhesion molecules to promote formation of a synaptic adhesion and facilitate the recruitment of pre-and postsynaptic machinery at new synapses. Our finding that the SPARC-like fragment of hevin can mimic SPARC and antagonize the synaptogenic function of hevin provides evidence that SPARC competes for a common binding partner with hevin. Future structure-function analyses of hevin and SPARC will help to identify neuronal receptors and signaling mechanisms involved in astrocyte-induced excitatory synapse formation.
What is the role of Hevin/SPARC signaling in synapse formation in vivo? To address this question, we focused on the optic tectum of mice (i.e., the SC, where RGC axons form excitatory synaptic contacts). RGC axons reach their targets at the SC before birth, but the vast majority of synaptic contacts are formed in the SC during the second and third week of postnatal development. Immunohistochemistry and Western blotting analyses of SC from mice at various postnatal time points with antibodies specific for hevin or SPARC showed that both proteins are expressed by astrocytes in the developing SC. Expression of hevin and SPARC are low during the first postnatal week, but rapidly increase, peaking at approximately the second to third week, which correlates with the peak of the synaptogenic period in the SC. Unlike TSP1 and -2, whose expression is decreased during maturation, hevin expression remains high throughout adulthood. SPARC expression is decreased in the adult SC, but some SPARC protein is still present.
To test directly whether hevin and SPARC are involved in the formation of synapses by RGC axons onto their SC targets, we analyzed synapse numbers at postnatal day 14 (P14), an age at which the synaptogenesis in the SC is at its peak, in hevinnull or SPARC-null mice at the superficial layer of the SC and compared them with those present in WT mice of corresponding genetic backgrounds. We stained sagittal SC sections with an antibody against a presynaptic marker that is specific for RGC synaptic terminals, the vesicular glutamate transporter 2, and a marker for glutamatergic postsynaptic specializations known as PSD95, and quantified the number of colocalized synaptic markers by using techniques we have previously developed (1, 2, 5) . We found that, at P14, there were significantly fewer synapses in hevin-null mice compared with WT mice. Conversely, at P14, SPARC-null mice had higher numbers of excitatory synapses in the SC compared with WT mice. These results show that hevin is a synapse-promoting factor, whereas SPARC is an inhibitor of excitatory synapse formation in vivo.
RGC axonal terminals in SC are characterized by large presynaptic boutons, or knoblike enlargements laden with synaptic vesicles located at the end of axons, where synapses form with other neurons. In hevin-null mice, these boutons (visualized by vesicular glutamate transporter 2 staining) were noticeably smaller in size, suggesting fewer synaptic vesicles were present at synapses in hevin-null mice. We analyzed synaptic structure in hevin-null mice by examining the fine structure of the asymmetric (i.e., excitatory) synapses within the superficial gray layer, stratum griseum superficiale (SGS), of the SC by EM. We focused on SGS because the vast majority of asymmetric/excitatory synapses in this region of SC are made by retinal projections of RGCs. Morphometric analysis of asymmetric synapses at the SGS of P25 mice showed that, in hevin-null mice, asymmetric synapses had thinner PSDs (39% less), larger synaptic cleft distances (41% more), and smaller presynaptic terminals (37% less), with significantly less synaptic vesicles (>50% less) compared with WT mice. These morphological defects in hevin-null mice show that RGC synapses do not recruit pre-and postsynaptic machinery efficiently and mature properly in the absence of hevin.
Taken together, our results identify astrocyte-secreted proteins hevin and SPARC as factors that stimulate or inhibit formation and maturation of excitatory synapses (Fig. P1) . Competitive equilibrium between these two proteins could provide a molecular mechanism that underlies the temporal and spatial regulation of synapse formation, maturation, and plasticity in the CNS. Astrocytes, through regulation of relative levels of hevin and SPARC, might dynamically control the formation and remodeling of excitatory synapses in the developing and adult brain, and thus may actively contribute to learning and behavior. Future studies to investigate the role of hevin and SPARC in synaptic and cognitive function, learning, and plasticity will enable us to understand the full extent of the functions of these molecules and astrocytes in the CNS.
